ESC Professional Premium Access

The effect of iron deficiency treatment with intravenous ferric carboxymaltose on the arrhythmic burden of patients with HFrEF and cardiac implantable electronic devices

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Congress Presentation

About the speaker

Mr Anastasios Tsarouchas

Hippokration General Hospital of Thessaloniki, Thessaloniki (Greece)
0 follower

6 more presentations in this session

Repetitive LevosimenDan infusions fOR patients with advanced chronic heart failure in the vulnerable post-discharge period: the multinational randomized LeoDOR trial

Speaker: Associate Professor G. Polzl (Innsbruck, AT)

Thumbnail

Deep learning model to identify potential occurrence of reduced LVEF in patients with implantable loop recorders

Speaker: Doctor J. Howard (London, GB)

Thumbnail

Effect of vericiguat on cardiovascular outcomes in patients with heart failure with and without diabetes: Insights from the VICTORIA trial

Speaker: Doctor J. Butler (Dallas, US)

Thumbnail

Prognostic value of three iron deficiency definitions in patients with advanced heart failure

Speaker: Doctor J. Reinhold (Norwich, GB)

Thumbnail

Accelerometer-measured physical activity in patients with heart failure and reduced ejection fraction: determinants and relationship with patient-reported health status

Speaker: Doctor J. Larsen (Odense, DK)

Thumbnail

Access the full session

HFrEF pathophysiology

Speakers: Mr A. Tsarouchas, Associate Professor G. Polzl, Doctor J. Howard, Doctor J. Butler, Doctor J. Reinhold...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations